| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 170.019 | 159.988 | 158.015 | 162.932 | 171.800 | 207.983 | 214.260 | 221.718 | 271.496 | 299.834 |
| Total Income - EUR | 170.157 | 166.697 | 158.028 | 162.937 | 171.959 | 208.443 | 218.753 | 223.084 | 272.111 | 299.928 |
| Total Expenses - EUR | 155.678 | 153.528 | 146.644 | 152.116 | 158.691 | 180.868 | 185.451 | 205.660 | 257.482 | 282.190 |
| Gross Profit/Loss - EUR | 14.479 | 13.168 | 11.384 | 10.821 | 13.269 | 27.576 | 33.302 | 17.424 | 14.628 | 17.738 |
| Net Profit/Loss - EUR | 12.287 | 10.872 | 9.620 | 9.183 | 11.536 | 25.988 | 31.317 | 15.432 | 12.168 | 14.403 |
| Employees | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
Check the financial reports for the company - Biovital S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 73.923 | 59.607 | 51.934 | 45.704 | 40.612 | 38.361 | 40.866 | 60.054 | 51.391 | 41.548 |
| Current Assets | 60.907 | 50.174 | 61.530 | 68.456 | 74.811 | 93.127 | 112.579 | 99.681 | 109.397 | 114.345 |
| Inventories | 24.393 | 27.439 | 27.070 | 27.662 | 25.571 | 36.115 | 32.627 | 46.114 | 51.629 | 52.499 |
| Receivables | 16.733 | 6.550 | 19.103 | 24.213 | 21.457 | 28.563 | 29.060 | 32.779 | 39.112 | 32.074 |
| Cash | 19.780 | 16.185 | 15.357 | 16.580 | 27.784 | 28.449 | 50.892 | 20.789 | 18.656 | 29.772 |
| Shareholders Funds | 114.878 | 98.092 | 106.052 | 106.502 | 108.878 | 124.967 | 143.406 | 148.125 | 145.693 | 139.178 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 20.352 | 12.372 | 7.720 | 7.657 | 6.546 | 7.178 | 10.039 | 11.756 | 15.095 | 16.715 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Biovital S.r.l.